Browne L Daniel

Avg. Two Year Performance

6% Avg. Purchase Return
3% Compound
(< 1%) Avg. Sale Return
0% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return< 1%(1%)53%135%6%
Purchase Success Rate1 of 10 of 11 of 11 of 11 of 1
Average Sale Return(8%)(7%)(13%)(23%)(< 1%)
Sale Success Rate4 of 122 of 122 of 122 of 121 of 12
Drugs » Biotechnology

CEO and President, Director:

Holdings: 152.6K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--